The objective of this study was to assess the association between receipt of BNT162b2 mRNA vaccine and risk of SARS-CoV-2 infection among pregnant women | JAMA

The retrospective cohort study that included 15 060 pregnant women in Israel, found that vaccination with BNT162b2 vs nonvaccination was associated with an adjusted hazard ratio for incident SARS-CoV-2 infection of 0.22; this was statistically significant.

The authors conclude thatamong pregnant women, receipt of the BNT162b2 vaccine was associated with a lower risk of incident SARS-CoV-2 infection.

Full detail: Association between BNT162b2 vaccination and incidence of Sars-cov-2 infection in pregnant women


This free site is ad-supported. Learn more